News Focus
News Focus
icon url

DewDiligence

03/08/13 9:39 PM

#158018 RE: BTH #158016

Shareholders of biotech companies that get acquired almost invariably think the buyout price is too low. That’s what makes ELN such a refreshing counterpoint.